Giorgi Kharebava

972 total citations
15 papers, 808 citations indexed

About

Giorgi Kharebava is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Giorgi Kharebava has authored 15 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Developmental Neuroscience. Recurrent topics in Giorgi Kharebava's work include Neuroscience and Neuropharmacology Research (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Epigenetics and DNA Methylation (2 papers). Giorgi Kharebava is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Epigenetics and DNA Methylation (2 papers). Giorgi Kharebava collaborates with scholars based in United States, Poland and United Kingdom. Giorgi Kharebava's co-authors include Michal Hetman, Katarzyna Kalita, Jing‐Juan Zheng, Shirish Barve, Hee‐Yong Kim, Karl Kevala, Erzsebet M. Szatmari, Hee‐Yong Kim, Ji‐Won Lee and Craig J. McClain and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Giorgi Kharebava

15 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgi Kharebava United States 15 398 241 114 99 91 15 808
Tamás Gáspár United States 16 387 1.0× 199 0.8× 231 2.0× 38 0.4× 158 1.7× 25 783
Hiroshi Onogi Japan 17 281 0.7× 132 0.5× 94 0.8× 44 0.4× 119 1.3× 32 962
Bei Miao China 14 307 0.8× 157 0.7× 84 0.7× 77 0.8× 198 2.2× 30 715
Regino Perez‐Polo United States 19 361 0.9× 281 1.2× 230 2.0× 82 0.8× 202 2.2× 29 1.1k
Hirofumi Miyazaki Japan 17 484 1.2× 217 0.9× 38 0.3× 70 0.7× 167 1.8× 34 997
Evelyn J. Perez United States 10 373 0.9× 174 0.7× 87 0.8× 40 0.4× 212 2.3× 13 974
Antonio Cárdenas Spain 17 380 1.0× 249 1.0× 96 0.8× 69 0.7× 216 2.4× 19 1.0k
Marcus F. Keep United States 17 528 1.3× 269 1.1× 104 0.9× 36 0.4× 137 1.5× 22 948
Shozo Goto United States 9 393 1.0× 163 0.7× 85 0.7× 58 0.6× 73 0.8× 11 904
Song Jiao China 16 643 1.6× 386 1.6× 37 0.3× 74 0.7× 191 2.1× 36 1.2k

Countries citing papers authored by Giorgi Kharebava

Since Specialization
Citations

This map shows the geographic impact of Giorgi Kharebava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgi Kharebava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgi Kharebava more than expected).

Fields of papers citing papers by Giorgi Kharebava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgi Kharebava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgi Kharebava. The network helps show where Giorgi Kharebava may publish in the future.

Co-authorship network of co-authors of Giorgi Kharebava

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgi Kharebava. A scholar is included among the top collaborators of Giorgi Kharebava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgi Kharebava. Giorgi Kharebava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Myers, Scott A., Jingwen Zhang, Giorgi Kharebava, et al.. (2017). Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology. 125. 376–385. 39 indexed citations
2.
Lee, Ji‐Won, Bill X. Huang, Md Abdur Rashid, et al.. (2016). Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. Nature Communications. 7(1). 13123–13123. 123 indexed citations
3.
Kharebava, Giorgi, et al.. (2015). N-docosahexaenoylethanolamine regulates Hedgehog signaling and promotes growth of cortical axons. Biology Open. 4(12). 1660–1670. 22 indexed citations
4.
Katakura, Masanori, et al.. (2013). N‐docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. Journal of Neurochemistry. 125(6). 869–884. 76 indexed citations
5.
Kirpich, Irina, Jingwen Zhang, Leila Gobejishvili, et al.. (2013). Binge Ethanol-Induced HDAC3 Down-RegulatesCpt1αExpression Leading to Hepatic Steatosis and Injury. Alcoholism Clinical and Experimental Research. 37(11). 1920–1929. 31 indexed citations
6.
Kirpich, Irina, Smita Ghare, Jingwen Zhang, et al.. (2012). Binge Alcohol–Induced Microvesicular Liver Steatosis and Injury are Associated with Down‐Regulation of Hepatic Hdac1, 7, 9, 10, 11 and Up‐Regulation of Hdac3. Alcoholism Clinical and Experimental Research. 36(9). 1578–1586. 56 indexed citations
7.
Wu, Junfang, Giorgi Kharebava, Bogdan A. Stoica, et al.. (2012). Inhibition of E2F1/CDK1 Pathway Attenuates Neuronal Apoptosis In Vitro and Confers Neuroprotection after Spinal Cord Injury In Vivo. PLoS ONE. 7(7). e42129–e42129. 54 indexed citations
8.
Kabadi, Shruti V., Bogdan A. Stoica, Marie Hanscom, et al.. (2011). CR8, a Selective and Potent CDK Inhibitor, Provides Neuroprotection in Experimental Traumatic Brain Injury. Neurotherapeutics. 9(2). 405–421. 44 indexed citations
9.
Kharebava, Giorgi, et al.. (2008). Requirement of 3-Phosphoinositide-Dependent Protein Kinase-1 for BDNF-Mediated Neuronal Survival. Journal of Neuroscience. 28(44). 11409–11420. 28 indexed citations
10.
Gobejishvili, Leila, Prachi Hote, Aditya Barve, et al.. (2008). Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Research. 19(3). 358–369. 35 indexed citations
11.
Szatmari, Erzsebet M., Katarzyna Kalita, Giorgi Kharebava, & Michal Hetman. (2007). Role of Kinase Suppressor of Ras-1 in Neuronal Survival Signaling by Extracellular Signal-Regulated Kinase 1/2. Journal of Neuroscience. 27(42). 11389–11400. 24 indexed citations
12.
Kalita, Katarzyna, Giorgi Kharebava, Jing‐Juan Zheng, & Michal Hetman. (2006). Role of Megakaryoblastic Acute Leukemia-1 in ERK1/2-Dependent Stimulation of Serum Response Factor-Driven Transcription by BDNF or Increased Synaptic Activity. Journal of Neuroscience. 26(39). 10020–10032. 70 indexed citations
13.
Hetman, Michal & Giorgi Kharebava. (2006). Survival Signaling Pathways Activated by NMDA Receptors. Current Topics in Medicinal Chemistry. 6(8). 787–799. 121 indexed citations
14.
Seyfried, Jan, Xin Wang, Giorgi Kharebava, & Cathy Tournier. (2005). A Novel Mitogen-Activated Protein Kinase Docking Site in the N Terminus of MEK5α Organizes the Components of the Extracellular Signal-Regulated Kinase 5 Signaling Pathway. Molecular and Cellular Biology. 25(22). 9820–9828. 38 indexed citations
15.
Habas, Agata, Giorgi Kharebava, Erzsebet M. Szatmari, & Michal Hetman. (2005). NMDA neuroprotection against a phosphatidylinositol‐3 kinase inhibitor, LY294002 by NR2B‐mediated suppression of glycogen synthase kinase‐3β‐induced apoptosis. Journal of Neurochemistry. 96(2). 335–348. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026